1. Home
  2. RNA vs QLYS Comparison

RNA vs QLYS Comparison

Compare RNA & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • QLYS
  • Stock Information
  • Founded
  • RNA 2012
  • QLYS 1999
  • Country
  • RNA United States
  • QLYS United States
  • Employees
  • RNA N/A
  • QLYS N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • QLYS Computer Software: Prepackaged Software
  • Sector
  • RNA Health Care
  • QLYS Technology
  • Exchange
  • RNA Nasdaq
  • QLYS Nasdaq
  • Market Cap
  • RNA 4.4B
  • QLYS 4.4B
  • IPO Year
  • RNA 2020
  • QLYS 2012
  • Fundamental
  • Price
  • RNA $29.31
  • QLYS $135.73
  • Analyst Decision
  • RNA Strong Buy
  • QLYS Hold
  • Analyst Count
  • RNA 14
  • QLYS 17
  • Target Price
  • RNA $68.00
  • QLYS $137.36
  • AVG Volume (30 Days)
  • RNA 1.4M
  • QLYS 294.4K
  • Earning Date
  • RNA 08-08-2025
  • QLYS 08-05-2025
  • Dividend Yield
  • RNA N/A
  • QLYS N/A
  • EPS Growth
  • RNA N/A
  • QLYS 13.46
  • EPS
  • RNA N/A
  • QLYS 4.89
  • Revenue
  • RNA $8,927,000.00
  • QLYS $621,665,000.00
  • Revenue This Year
  • RNA N/A
  • QLYS $9.64
  • Revenue Next Year
  • RNA $155.06
  • QLYS $6.65
  • P/E Ratio
  • RNA N/A
  • QLYS $27.74
  • Revenue Growth
  • RNA N/A
  • QLYS 9.14
  • 52 Week Low
  • RNA $21.51
  • QLYS $112.61
  • 52 Week High
  • RNA $56.00
  • QLYS $170.00
  • Technical
  • Relative Strength Index (RSI)
  • RNA 42.04
  • QLYS 46.18
  • Support Level
  • RNA $31.59
  • QLYS $137.35
  • Resistance Level
  • RNA $38.00
  • QLYS $140.98
  • Average True Range (ATR)
  • RNA 2.01
  • QLYS 2.75
  • MACD
  • RNA -0.59
  • QLYS -0.84
  • Stochastic Oscillator
  • RNA 9.67
  • QLYS 10.37

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About QLYS Qualys Inc.

Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.

Share on Social Networks: